Oriva

Project Overview
University
Year
About
Neonatal sepsis can quickly become life-threatening, but blood cultures may take days and require blood from vulnerable newborns. Oriva uses a gentle handheld collector to obtain a saliva sample, which is processed in a portable microfluidic testing unit. The system measures sepsis-related biomarkers and sends the results to a digital interface in about two hours. Designed for clinics with limited laboratory infrastructure, it could support earlier treatment decisions, reduce unnecessary antibiotic use and expand access to newborn diagnostics in underserved regions.

